Oasis Pharma And Phytomolecules Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 08-07-2024
- Paid Up Capital ₹ 8.00 Cr
as on 08-07-2024
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.20 Cr
as on 08-07-2024
- Satisfied Charges ₹ 8.97 Cr
as on 08-07-2024
- Revenue 32971.90%
(FY 2021)
- Profit 43.02%
(FY 2021)
- Ebitda 30.41%
(FY 2021)
- Net Worth -90.07%
(FY 2021)
- Total Assets -13.72%
(FY 2021)
About Oasis Pharma And Phytomolecules
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 8.00 Cr.
The company currently has active open charges totaling ₹7.20 Cr. The company has closed loans amounting to ₹8.97 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjeev Kumar and Sanjay Dhir serve as directors at the Company.
- CIN/LLPIN
U24100CH2007PTC045485
- Company No.
163076
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 May 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
East Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Oasis Pharma And Phytomolecules?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Dhir  | Managing Director | 15-Jan-2015 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjeev Kumar | Director | 12-Dec-2014 | Current |
Financial Performance and Corporate Structure Insights of Oasis Pharma And Phytomolecules.
Oasis Pharma And Phytomolecules Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 32971.9% increase. The company also saw a substantial improvement in profitability, with a 43.02% increase in profit. The company's net worth observed a substantial decline by a decrease of 90.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oasis Pharma And Phytomolecules?
In 2021, Oasis Pharma And Phytomolecules had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Quixotic Pharma Private LimitedActive 22 years 21 daysSanjeev Kumar and Sanjay Dhir are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Jun 2022 | ₹6.90 Cr | Open |
Deputy Director Of Industries Creation Date: 01 Jan 2014 | ₹3.00 M | Open |
Hdfc Bank Limited Creation Date: 30 Nov 2016 | ₹4.17 Cr | Satisfied |
How Many Employees Work at Oasis Pharma And Phytomolecules?
Oasis Pharma And Phytomolecules has a workforce of 11 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oasis Pharma And Phytomolecules, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oasis Pharma And Phytomolecules's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
